Drug Profile
Losoxantrone - Pfizer
Alternative Names: Biantrazole; CI 941; DUP 941; NSC 357885; PD 113785Latest Information Update: 16 Jan 2008
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Bristol-Myers Squibb; Pfizer
- Class Anthraquinones; Antineoplastics; Pyrazolones; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Breast cancer
- Discontinued Prostate cancer